← Leaderboards
David Shibata
H. Lee Moffitt Cancer Ctr & Res Inst
$3,836,288
Attributed
$12,717,063
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.6M · FY2009–25$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,717,063 · 4
By mechanism
U01$9,251,154 · 1
R01$3,066,218 · 2
R21$399,691 · 1
Top collaborators
- Cornelia M Ulrich10 shared
- Jane C. Figueiredo8 shared
- Adetunji T Toriola8 shared
- Doratha Armenthus Byrd7 shared
- Biljana Gigic6 shared
- Erin Siegel5 shared
- Martin Schneider2 shared
- Christopher I Li1 shared
Most similar at H. Lee Moffitt Cancer Ctr & Res Inst
Same institution · by research overlap
- Shari Pilon-Thomas$5,168,533
- Erin Siegel$3,114,161
- Sungjune Kim$2,641,607
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsDiagnosisClinical DataColorectal CancerInterestBiological MarkersCessation Of LifeFecesSiteTumor TissueCancer PrognosisResourcesScienceSamplingUrineBloodColon Cancer PatientsMolecularProspectiveGeographyColorectal Cancer TreatmentInnovationInterdisciplinary StudyData Reporting
Grant awards (17)
Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare Study$1,724,414
U01 · FY2025 · CA
Body composition and adiposity-associated thromboinflammation in colorectal cancer prognosis$664,642
R01 · FY2025 · CA
Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare Study$95,364
U01 · FY2025 · CA
Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare Study$91,144
U01 · FY2025 · CA
Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare Study$1,788,840
U01 · FY2024 · CA
Body composition and adiposity-associated thromboinflammation in colorectal cancer prognosis$723,643
R01 · FY2024 · CA
Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare Study$95,210
U01 · FY2024 · CA
Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare Study$1,848,714
U01 · FY2023 · CA
Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare Study$1,670,811
U01 · FY2022 · CA
Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare Study$1,936,657
U01 · FY2021 · CA
Epigenomic Signatures of Radiation Sensitivity in HPV-associated Cancers$176,207
R21 · FY2017 · CA · contact PI
Epigenomic Signatures of Radiation Sensitivity in HPV-associated Cancers$223,484
R21 · FY2016 · CA · contact PI
STAT1 Activation and HPP1 Tumor Suppression$315,962
R01 · FY2013 · CA · contact PI
STAT1 Activation and HPP1 Tumor Suppression$336,129
R01 · FY2012 · CA · contact PI
STAT1 Activation and HPP1 Tumor Suppression$336,129
R01 · FY2011 · CA · contact PI
STAT1 Activation and HPP1 Tumor Suppression$346,525
R01 · FY2010 · CA · contact PI
STAT1 Activation and HPP1 Tumor Suppression$343,188
R01 · FY2009 · CA · contact PI